Realcan Pharmaceutical Group Co., Ltd.

002589

CNE1000013X5

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
2.68 ^CNY	-.--%		+11.67%	-18.04%

Apr. 29	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Realcan Pharmaceutical Group Co., Ltd. Announces Profit Distribution Proposal for 2021

May 05, 2022 at 03:39 pm EDT

Realcan Pharmaceutical Group Co., Ltd. announced on 05 May 2022 the profit distribution proposal for 2021 as follows: Cash dividend/10 shares (tax included): CNY 0.09000000.

Latest news about Realcan Pharmaceutical Group Co., Ltd.

Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 29	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-30	CI
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) added to S&P Global BMI Index	23-09-18	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Realcan Pharmaceutical Group Co., Ltd. Approves the Executive Appointments	23-05-22	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Shanghai Pharmaceutical Co., Ltd. entered into an agreement to acquire 51% stake in Hunan Runji Pharmaceutical Co., Ltd. from Realcan Pharmaceutical Group Co., Ltd. for CNY 149 million	23-01-16	CI
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire 9.6409% of Shandong Lekang Jinyue Industrial Co., Ltd. from Yantai Chenghou Investment Co., Ltd for CNY 84.84 million.	22-12-15	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-30	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Realcan Pharmaceutical Group Co., Ltd. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payable on July 22, 2022	22-07-14	CI
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) dropped from S&P Global BMI Index	22-06-20	CI
Realcan Pharmaceutical Group Co., Ltd. Approves Cash Dividend for the Year 2021	22-05-24	CI
Realcan Pharmaceutical Group Co., Ltd. Announces Profit Distribution Proposal for 2021	22-05-05	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Realcan Pharmaceutical Group Co., Ltd. agreed to acquire a 38.39992% stake in Tianjin Guohui Big Health Technology Co., Ltd. from Yantai Huishuo Enterprise Management Partnership Enterprise for approximately CNY 230 million.	22-02-17	CI
Realcan Pharmaceutical Group Co., Ltd. acquired Health Technology for approximately CNY 230 million.	22-02-16	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Realcan Pharmaceutical Group Co., Ltd.(XSEC:002589) dropped from FTSE All-World Index	21-09-20	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-30	CI
Realcan Pharmaceutical Group Co., Ltd. Announces Cash Dividend on A Shares for the Year 2020, Payable on June 23, 2021	21-06-17	CI
Realcan Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-29	CI
Realcan Pharmaceutical Group Co., Ltd. Approves Dividend for 2020	21-04-23	CI
Exxon, activist spend over $65 million in battle for oil giant's future	21-04-15	RE
Realcan Pharmaceutical Co., Ltd. Final Announces Profit Distribution Proposal for 2020	21-03-31	CI

Chart Realcan Pharmaceutical Group Co., Ltd.

Duration

Period

Chart Realcan Pharmaceutical Group Co., Ltd.

More charts

Realcan Pharmaceutical Group Co., Ltd., formerly REALCAN PHARMACEUTICAL CO., LTD., is a China-based medical service provider. The Company operates its businesses through three segments. The Medical segment is engaged in the provision of Chinese medicine materials, Chinese medicine tablets, Chinese patent medicines, chemical drug materials, chemical preparations, antibiotics, biochemical pharmaceuticals, biological products, psychotropic substances, anesthetic medicines and peptide hormones. The Equipment is engaged in the provision of medical equipment. The Mobile Medical segment is engaged in the provision of medical and logistics services and mobile medical information services. The Company conducts its businesses mainly within domestic markets, with Shandong as its main market.

Sector

Pharmaceuticals

Calendar

2024-08-26 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
REALCAN PHARMACEUTICAL GROUP CO., LTD.	-18.04%	557M
MCKESSON CORPORATION	+16.03%	70.59B
CARDINAL HEALTH, INC.	+2.22%	25.06B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+7.11%	8.2B
SINOPHARM GROUP CO. LTD.	-2.98%	7.92B
HUADONG MEDICINE CO., LTD	-20.55%	7.96B
H. LUNDBECK A/S	+3.30%	4.71B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.12%	4.32B
EBOS GROUP LIMITED	-1.24%	4.01B
GALENICA AG	-3.44%	3.82B

Pharmaceuticals Wholesale